Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Blackhawk Growth Corp C.BLR.WT


Primary Symbol: C.BLR Alternate Symbol(s):  BLRZF

Financial Services Asset Management
Blackhawk Growth Corp. is a Canada-based investment holding company. The Company invests in equity and debt instruments of companies to generate positive returns for shareholders. It focuses on investing in multiple companies across a variety of sectors across North America. The Company has focused its investments on the health, cannabis and cannabidiol (CBD) industries, in both Canada and the... see more

Recent & Breaking News (CSE:BLR)

Blackhawk Growth's Spaced Food To Launch In Canada's Largest Market

TheNewsWire December 19, 2022

Blackhawk Growth Receives Court Approval to Hold Special Meeting on December 22nd 2022 to Approve Mindbio Therapeutics Spinout

TheNewsWire December 2, 2022

Blackhawk Growth Announces Shareholder Meeting for December 22, 2022 to Vote on the Spin-Out of Mindbio Therapeutics

TheNewsWire November 7, 2022

Blackhawk's Mindbio Reveals Positive Data From Phase 1 Randomised Double-Blind Placebo Controlled Clinical Trials Microdosing LSD In 80 Healthy Participants

TheNewsWire November 4, 2022

BlackHawk Growth (CSE:BLR) reprofiles $10M loan and adds $2M facility

Caroline Egan  October 28, 2022

Blackhawk Growth to Reprofile Existing Credit Facility and Add Additional $2 Million Dollar Facility

TheNewsWire October 28, 2022

BLACKHAWK's Mindbio Announces Phase 2A/B Clinical Trials Microdosing LSD in Major Depressive Disorder Submitted for Ethics & Regulatory Approval

TheNewsWire September 28, 2022

BLACKHAWK's Mindbio Nominated for Company of the Year by Industry Peers as it Prepares for Phase 2 Clinical Trials

TheNewsWire September 22, 2022

Blackhawk's MindBio Therapeutics Announces Reveal Date for Presentation of Phase 1 Clinical Trial Data

TheNewsWire September 15, 2022

Blackhawk Growth's Spaced Food Manufacturing Partner Completes Development of Spaced Food Edibles; Prepares for Commercial Production

TheNewsWire August 29, 2022

Blackhawk Growth Sets AGM Date and Provides Corporate Update

TheNewsWire August 9, 2022

Blackhawk's Mindbio Therapeutics Announces Research Collaborators at University of Auckland Receive Grant Funding of $1.44 Million for LSD Microdosing Trials in Major Depressive Disorder

TheNewsWire July 25, 2022

Blackhawk's Terp Wholesale LLC Reports Unaudited Cdn$1,644,043 in Gross Revenue for First Five Months Ended May 31st, 2022

TheNewsWire June 16, 2022

Blackhawk Appoints Justin Hanka as Chairman of The Board

TheNewsWire June 6, 2022

Blackhawk Growth Files Quarter Ended March 31, 2022 Financials and Reports Increase in Value of its Portfolio by 8.8% Quarter Over Quarter

TheNewsWire May 30, 2022

Blackhawk's Terp Wholesale LLC Expands Facility, Launches Retail Delivery

TheNewsWire May 24, 2022

Blackhawk's Mindbio Therapeutics Accelerates Global Communications Expansion Ahead of Phase 2 Clinical Trials

TheNewsWire May 11, 2022

Blackhawk's MindBio Therapeutics Announces Completion of World First Phase 1 Microdosing Clinical Trial

TheNewsWire May 3, 2022

Blackhawk Growth Closes Investment in Blum Distributors

TheNewsWire April 28, 2022

BLACKHAWK GROWTHS Blum Distributors Expands Facility and Starts to Fulfill Applied Myco Order

TheNewsWire April 19, 2022